RapidAI

RapidAI is an enterprise platform that delivers deep clinical AI for decision support across neurovascular, cardiac, vascular, and radiology care. It helps healthcare professionals—including physicians, care teams, hospital administrators, and IT—identify suspected anomalies, localize regions of concern, automate key metrics, assess severity, visualize AI outputs in 3D, and track changes over time. The platform is backed by extensive clinical validation with over 700 publications and 25+ clinical trials. It includes a mobile app for real-time collaboration and alerts, an imaging prioritization tool (Navigator Pro), a custom performance analytics platform (Rapid Insights), and an interoperability framework for third-party integration. RapidAI aims to enhance patient outcomes, drive operational efficiency, and strengthen financial viability for health systems.

Key Features

• Deep Clinical AI: Provides triage, localization, quantification, characterization, visualization, and longitudinal tracking for disease states such as stroke, aneurysm, aortic conditions, and pulmonary embolism.
• Rapid Mobile App: Enables real-time notifications, DICOM viewer, in-app messaging, consultation, customizable alerts, single-touch procedural workflows, and EMR-integrated case summaries.
• Enterprise Platform: Supports cross-disciplinary deployment of AI across the health system.
• Clinical Validation: Over 700 publications, 25+ clinical trials, 11 NEJM publications, and a 17.5 impact factor.

Who It’s For

• Physicians
• Care teams
• Hospital administrators
• IT departments

Use Cases

• Stroke triage and treatment decisions
• Aneurysm detection and monitoring
• Cardiac and vascular care pathways
• Radiology workflow prioritization
• Life sciences clinical trials

Key Benefits

• Extensive clinical validation with 700+ publications and 25+ trials
• Real-time AI insights for faster, more confident decision-making